Genezen will be attending the International Society of Cell and Gene Therapy’s 2022 conference in San Francisco this May.
From idea to bench and bench to trial, we leverage over a decade of experience in viral vector process development and manufacturing services. Be sure to stop by booth #519 to speak to our team about how we can help with your project and learn about our new state-of-the-art, cGMP-compliant lentiviral and retroviral vector production facility.
Will we see you there? Get in touch with us to book a meeting ahead of time.